CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period

ATRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth



ATRA Quick Ratio for Trailing Twelve Months Period

(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
Y / Y Current Liabilities Growth 79.19 % 88.51 % 144.34 % 20.66 % 14.74 %
Y / Y Cash & cash equivalent Growth 92.18 % 76.54 % -35.04 % -27.95 % -26.3 %
Quick Ratio for Trailing Twelve Months Period 15.79 14.94 13.7 19.88 23.02
Total Ranking # 151 # 152 # 158 # 84 # 67
Seq. Current Liabilities Growth 39.83 % -37.76 % 43.13 % 43.86 % 47.1 %
Seq. Cash & cash equivalent Growth 2.38 % 145.35 % -17.12 % -7.68 % -5.96 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Atara Biotherapeutics, Inc. Cash & cash equivalent average soared by 92.18 % in II. Quarter year on year, faster than Current Liabilities, this led to increase in in Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period to 15.79, Quick Ratio for Trailing Twelve Months Period remained below Atara Biotherapeutics, Inc. average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 11 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Atara Biotherapeutics. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 151, from total ranking in previous quarter at 152.

What is Quick Ratio?
Learn more about ATRA
Quick Ratio ATRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 12
Sector # 46
S&P 500 # 146


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
35.85 24.99 12.84
(June 30. 2016)   (Dec 31 2017)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2018, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Krystal Biotech, Inc.  34.10 
Protokinetix, Inc.  26.87 
Gtx Inc  22.80 
Fennec Pharmaceuticals Inc.  19.91 
Atara Biotherapeutics, Inc.  19.63 
Crispr Therapeutics Ag  19.53 
Iovance Biotherapeutics, Inc.  18.71 
Acceleron Pharma Inc  18.40 
Microbot Medical Inc.  18.23 
Enzon Pharmaceuticals, Inc.  17.44 
Audentes Therapeutics, Inc.  15.45 
Casi Pharmaceuticals, Inc.  15.34 
Catalyst Biosciences, Inc.  14.07 
Aerie Pharmaceuticals Inc  14.01 
G1 Therapeutics, Inc.  13.39 
Voyager Therapeutics, Inc.  12.91 
Novus Therapeutics, Inc.  12.87 
Aerpio Pharmaceuticals, Inc.  12.36 
La Jolla Pharmaceutical Co  12.29 
Pulse Biosciences, Inc.  12.19 
Organovo Holdings, Inc.  12.06 
Spark Therapeutics, Inc.  12.04 
Allena Pharmaceuticals, Inc.  11.64 
Neurocrine Biosciences Inc  11.52 
Bluebird Bio, Inc.  11.23 
Wave Life Sciences Ltd.  10.86 
Intellia Therapeutics, Inc.  10.66 
Fulgent Genetics, Inc.  10.13 
Alder Biopharmaceuticals Inc  9.23 
Cohbar, Inc.  9.03 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FXCH's Profile

Stock Price

FXCH's Financials

Business Description

Fundamentals

Charts & Quotes

FXCH's News

Suppliers

FXCH's Competitors

Customers & Markets

Economic Indicators

FXCH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071